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Summary. Multiple primary cancers of the breast and ovary were investigated as
part of a survey being undertaken at the Birmingham and West Midlands Regional
Cancer Registry. Population-based data relating to 17,756 registrations for breast
and 3470 for ovarian cancer between 1950 and 1964 were analysed. On the basis of
person-years at risk and incidence rates for the Region (1960-1962), an increased risk
of a second primary tumour in the ovary was observed in patients diagnosed with a
first primary in the breast before 45 years of age (O =8; E = 1*83; P<0 001). No excess
was found in patients diagnosed after 45 years of age (O=15; E=17.06). In patients
with an index tumour of the ovary, the observed number of second primary tumours
of the breast was not significantly different from the expected number (O=19;
E =12-95).
Complementary analysis (a combined assessment for the 2 sites) showed that the
development of a first primary at either site before 45 years of age carried a 2-8-fold
risk of a second primary tumour at the other site (0=9; E=3-21; P<0-01). After 45
years of age no increased risk was found (0=32; E=28-63). Over all ages a 1-3-fold
risk was observed (0=42; E=31 54; P<0-05).
No evidence of subfertility was found in the 9 patients in the high-risk premeno-
pausal group who developed the 2 tumours. The results are more consistent with an
aetiology of early exposure to an external carcinogen than with one of abnormal
hormone production.
A SURVEY of data held at the Birming-
ham Regional Cancer Registry is being
uindertaken to establish the incidence of
multiple primary cancers in the West
Midlands Region. A previous paper re-
ported the incidence of bilateral breast
cancer in the Region (Prior & Waterhouse,
1978) and indicated that such tumours
occurred at a higher rate in patients
diagnosed with a first primary in the pre-
menopausal period. Many independent
investigations suggest the implication
of endocrine hormones in the pathogenesis
of breast cancer as important factors in,
at least, promotion if not in initiation.
It does not seem unreasonable to suggest
then that otherhormone-dependent tissues
might also be at risk for cancer in a patient
with cancer of breast and that such a risk
miglht be revealed by the occurrence of
tumours at associated sites in the same
individual. Because of the close relation-
ship between ovarian activity and the
development and metabolism of breast
tissue, the incidence of tumours of ovary
and breast, occurring as multipleprimaries,
has been examined.
Previous studies
Previous reports on the association
between tumours of the breast and ovary
are summarized in Table I. Only those
surveys based on relatively large data
sources and using authenticated incidence
rates for computing expected nuLmbers of
tumours have been included. When breast
occurred as the first primary, 3 of the 5
analyses showed a significant excess of
second primaries in the ovary, RR being
about 2-fold. The fifth survey (NewellAIULTIPLE PRIMARY CANCERS OF THE BREAST AND OVARY
TABLE I.-Summary of reportsfor breast and ovary cancer
Author
Schoenberg et al. (1969)
Schottenfeld & Berg (1971)
Newell et al. (1974)
Newell et al. (1974)
Schoenberg (1977)
Schottenfeld & Berg (1971)
Schoenberg (1977)
Reimer et al. (1978)
1st 2nd
Primary Primar
Breast Ovary
Breast Ovary
Breast Ovary
(Whites)
Breast Ovary
(Blacks)
Breast Ovary
Ovary Breast
Ovary Breast
Ovary Breast
0
30
24
5
E
15-9
11-4
2-3
O/E
229**
2-1***
2-2
Data
source
C.T.R.
M.S.C.C.
C.H.
Incidence
rates
C.T.R.
N.Y.S.
T.C.S.
2 1-9 1.1 C.H. T.C.S.
60
7
25
83
35-1
1-6
17-9
77-1
1-7***
4-4**
1-4
1-1
C.T.R.
M.S.C.C.
C.T.R.
E.R.P.
C.T.R.
N.Y.S.
C.T.R.
C.T.R.
C.H. =Charity Hospital Tumor Registry, Louisiana; C.T.R. = Connecticut Tumor Registry; M.S.C.C. =
Memorial Sloan-Kettering Cancer Center; N.Y.S. =New York State; T.C.S. =Ten Cities Survey; E.R.P. =
End Results Program, N.C.I.
**P < 0-01; ***P < 0-001.
et al., 1974) suggested that there might be
a differential risk between "whites" and
"blacks", but the numbers involved were
probably too small for any firm conclusion.
Of the 3 reports available for the reverse
sequence of tumours (ovary followed by
breast) one indicated a significant excess
of second primary tumours in the breast,
RR being estimated as 4-4-fold from the
hospital-based data of the Memorial
Sloan-Kettering Cancer Centre, whereas
the 1P4-fold risk found in the population-
based series from the Connecticut Tumor
Registry did not reach the 5% significance
level. No significant excess was found in
the series from the End Results Program
data.
MATERIALS AND METHODS
Information held at the Birmingham
Regional Cancer Registry relates to a well-
defined geographical and administrative re-
gion comprising 5 counties with a total popu-
lation of 5 million. Covering both urban and
rural communities, it is representative of the
whole country. Data for the present analyses
included all registrations for cancer of the
breast and ovary between the years 1950 and
1964, all being followed to the 1965 anniver-
sary ofthe date offirst treatment, or to death
if this occurred earlier. Age distributions
within the 2 index sites are given in Table II.
In the first instance, the conventional
approach to analysis was used: taking each
index site in turn, only subsequent tumours
at the other site were considered. This
approach is referred to below as "Sequence"
TABLE lI.-Age distributions by index site
Breast Ovary
Age at
diagnosis No. (0) No. (O%)
15-44 2899 (16-3) 564 (16-3)
45-59 6549 (36.9) 1462 (42-1)
60+ 8308 (4658) 1444 (41-6)
Total 17756 (100) 3470 (100)
analysis and involves the following steps. For
each index site, the survival experienced by
each patient was computed and entered into
an array of "person-years" at risk in terms of
age at and interval from the diagnosis of the
first primary. Age-specific incidence rates for
cancer of the second primary site were com-
puted from registrations for the Birmingham
Region between the years 1960 and 1962,
together with the appropriate population
figures for the region obtained from the
Registrar General's Population Census in
1961. The number ofsecond primary tumours
that might be expected to occur during the
period of observation were computed by
applying the age-specific rates to the appro-
priate elements of the array of "person-
years" at risk. To allow for the inclusion of
coincidental diagnosis of tumours, the ex-
pected numbers were adjusted by the method
described elsewhere (Prior & Waterhouse,
1981a), involving a model in which the
parameters are the duration of a preclinical
period and of clinical surveillance. In this
context, "preclinical" tumours would be those
that might be discovered by routine examina-
tion. For example, small non-symptomatic
tumours of the breast might be discovered
during a preoperative examination for an
ovarian tumour, whereas a tumour of the
ovary might only be found in the breast
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cancer patient if it carried symptoms. Thus,
the preclinical period for ovariain tumours
Aas taken as the median duration of symp-
toms, that is 2 inonths, while for breast a
period of 16 months, used in previous
analyses, was used.
Finally, complementary analysis (Prior &
Waterhouse, 1981b), which combines infor-
mation from the sequence analyses, was
carried out. This approach attempts to reduce
any methodological bias that might be in-
herent in the sequence analyses.
Although the primary nature of second
tumours is generally assessed before registra-
tion, inetastases from either breast or ovary
are not uncommon at the other site. All cases
were, therefore, reviewed before being in-
cluded in the observed numbers of the
analyses.
The signiificanice of the differeinces between
observed and expected numbers was assessed
using the Poisson distribution.
RESULTS
Tracing to the requisite dates was
achieved for 99.500 of the breast series,
yielding 62,502 5 person-years at risk for
analysis. For the ovarian series tracing
reached 99-9%o with a yield of 7485-5
person-years.
Forty-two patients were diaginosed with
primary tumours at both sites. In 6 cases
the tumours were considered to be co-
incidental diagnoses; that is they were
diagnosed on the same day or within one
month of the other primary. Twenty-two
breast-cancer patients subsequently de-
veloped a tumour of the ovary and 14
patients with ovarian cancer developed a
tumour of the breast after an interval of
more than one month.
TABLE III. Sequence analysis: Observed
and expected numbers of second primary
tumours by index site
InIlex
s;ite
Breast
SeconI(I
primary
site
Ovary
Age at
1st
primary,
(years)
15-44
45-59
6(+
Total
Ovary Breast 15-44
45-59)
60+
Total
No. 2ii(n
primary
tuimoulrs
_
E 0
183 8
8 11
9 06 4
18 89 2:3
1:37 1
5 64 9
5.94 9)
12 95 19
O/E 1'
4.4 <0-001
1-4
0 4
12
0 7
1 6
1.5
1*5
E =exp)ected number; () =observe(1 number.
primary diagnosis are summarized for the
two series in Table III for 3 main age
ranges, which in the absence of precise
data were selected to reflect menopausal
status. In the context of this analysis the
results suggest that only those women who
were diagnosed with a breast tumour
before the age of 45 years were at an
increased risk of a subsequent tumour in
the ovary. In this group the excess of
ovarian tumours was highly significant
(P < 0 001). In women diagnosed with
ovarian cancer after the age of 45 years,
the small excess of subsequent breast
tumours did not reach statistical sig-
nificance. Over all ages neither series
showed a significant excess of subsequent
tumours.
Complementary analysis
Age at first primary diaynosis-.When
the two series were combined, the overall
excess of - 10 ttumours was of borderline
Sequence analysis
From the imodels it was computed that
7d)4 coincidental diagnoses might be
expected, I 29 attributed to the breast
series and 6-65 to the ovariani series. To
preserve the integer notation for observed
cases, the 6 observed coincidental cases
were distributed as I to the breast and 5
to the ovarian series.
The results in terms of age at first
'I'ABLE IV. Complementary analysis:
Breast and ovary. Observed and expected
naunbers ofsecond primary tumours
No. 2nd(
Age at pirimia.ry
Ist tumour1s
(years) E 0 0 ( 1
15 44 3:21 9 2580 <001
45-59 13 63 20 147
60()+ 15 13 0587
Total :3184 42 1 :32 < 0 05
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FIG. 1. Complementary analysis of breast
an(d ovary: observed ( ) an(t expecte(1
(----) ntumbers of secondl primary turmotirs
in relation to age at secon(l primary
dllaonos'is.
significance (P = 0.049). In women with a
first primary diagnosed before the age of
45 years (premenopausal group) the excess
of second primary tumours was highly
significant (P < 0 01 ), whereas neither the
excess in the perimenopausal group (45-59
years) nor the small deficit in the post-
nmenopausal group (60 + years) reached
statistical significance (Table IV). On
combining the latter two groups (45 +
years) a small excess of 4 tumours was
found.
Age at second primary diagnosis.
Complementary analysis shows that the
excess of second primary tumours occurs
before the age of 60 years. After this age,
the observed numbers were found to
fluctuate about the expected numbers
(Fig. 1).
Interval between diagnoses. There was
a 2-8-fold risk in the premenopausal group,
and despite the small numbers the cumula-
tive RR remained remarkably constant
over time. Although RR was somewhat
lower in the first year (2.4), over the
remaining years the cumulative risk was
about 3-fold, varying from 2 7 to 3 2.
10-0
8-0
6-0
4-0 ,
20
l. A
0 1 3 5 7 9 11 13 15
YEARS from ISt PRIMARY DIAGNOSIS
Fi'G. 2.--Complementary analysis of breast
and ovary: cumulativTe observ-ed ( )
and expecte(d ( --- ) numbers of tumours
in the breast oIr ovary in relation to the
interval from diagnosis of the first primary.
A, Ages 15-44. B, Ages 45+.
For those patients aged 45 and over, the
cumulative observed and expected num-
bers were close over the whole period and,
although a small excess was apparent, the
overall RR (1.2) was not significantly
different from l 0 (Fig. 2).
Details of the 42 cases with 2 primary
tumnours
Histology. Table V shows the distribu-
tion of the histological types of ovarian
tumours. For the 9 patients developing a
first primary in the premenopausal period,
7 were recorded as having papillary serous
cvstadenocarcinoma and 2 adenocarcinoma
of the ovary. The breast tumours in the
patients included carcinoma (1), car-
cinoma in association with fibrocystic
U-l .;I ,- A .: *, ,: . * _!
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TABLE V.-Histological type of ovarian cancer in 42 patients with 2 primary tumnours
Age, range at 1st primary (liagnosis
No. of patients (% ofage range)
I- A\
Histological type
Papillary serotis
cystadenocareimoma;
adenocarcinoma
P'seudomueinious carcitnoma
Granuilosa cell (areinoma
Teratoma
Not knowin
Total (% of total)
Pre- Pein- Post- All ages
menopausal menopauisal menIopausal (00,, of total)
9 (100) 13 (65)
3 (15)
2 (10)
2 (1()
9 (21-4) 20 (47-6)
6 (46-1)
4 (30-8)
2 (15-4)
1 (7-7)
13 (31)
28 (66-7)
7 (16-6)
2 (4-8)
2 (4-8)
3 (7-1)
42 (100)
disease (2), spheroidal-cell (
anaplastic (2) and undiffei
cinoma (1). The last patient
survive to develop a medull(
of the opposite breast, and
cinoma ofthe caecum as a fc
Pseudomucinous adenocarci
ovary was recorded only in
postmenopausal groups. Te
diagnosed in 2 perimenopa
and 2 granulosa-cell tumou:
in patients over 60 at first
Marital status and pa
status was unknown in on
patients with the 2 prim
Although the numbers are
portion of single women
similar to that in the genei
(11 700) for a group ofwome
The mean age at first prirr
was 56 years for the 42 obs
the survey.
TABLE VI. Menopausal
primary diagnosis and
patients with 2 primary tu)
Marital stat
Exer-mar rie(l
r
Pre-
melon-
Parity pausal Otlher
0 0 2
1 1 5
2 3 )
3 1
4 1
5 0 1
Not
known 1 17
Total 8 28,
All
2
6
5
3 I
18
36 (85-7%)
,arcinoma (3),
rentiated car-
did, however,
ary carcinoma
an adenocar-
)urth primary.
inoma of the
the peri- and
ratomas were
Information on parity was sparse for
patients over the age of 45 but in the
premenopausal group of "ever-married"
patients, the information was missing in
only one out of 8 cases. Even assuming
that this case was non-parous, the mean
numbers ofbirths was 2-3 (Table VI).
DISCUSSION
M;Sal wJ1L, Nhenbreast wastaken as the index site rs were found sequence analysis indicated a strong asso- primary. ciation between tumours of breast and ~rity. seuncanayisidiaedastoglso triyoneof the ovary in the premenopausal group, and
an apparent decrease in RR with increas-
taryllthmours ing age at first primary diagnosis. For the
00)waes reverse sequence of tumours, the associa- (11.9%) was tion was not so clear-cut. Small excesses or ral population deficits of observed tumours may arise ,n aged 55 59. from spurious divisions in the population iary diagnosis under consideration, and may therefore erved cases in
I
be the effect of methodology rather than
aetiology. Complementary analysis at-
tempts to make some allowance for effects status at 1st arising from methodology and, in this parity of 42 instance, while complementary analysis mnours supports the association in the premeno-
"us pausal group, with a more conservative
estimate of RR, it indicates that for the
remaining patients the observed number of
Not tumours (33) was close to the expected
Single known number (28.63). These results are strongly
suggestive that menopausal status is
important to the association. The raised,
but non-significant, risk in the perimeno-
pausal patients may therefore be due to
heterogeneity ofthis group with respect to
status.
5 (11 9) 1 (2 4%) Although problems in differential diag-
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nosis might, have beeni anticipated for
these two sites, complementary analysis
indicated that the cumulative RR in the
premenopausal group was constant over
the period of observation, at least after
the first 2 years. RR was somewhat lower
for these 2 years, which suggests that we
have been over-cautious in accepting the
presence of a second primary, probably
when one or both primaries presented at
a late stage.
Because of the different methods of
analysis, it is difficult to compare the
results from the Birmingham data with
other published reports. However, for
two series-Memorial Hospital, New York
(M.S.C.C.) and Connecticut Tumor Regis-
try (C.T.R.)-the results of sequence
analyses for pairs ofsites can be combined
to give an approximate parallel to comple-
mentary analysis. The overall RR for
breast wvith ovary then becomes 2 48
(O=31; E= 130) for M.S.C.C. and 1P6
(O=85; E=53.0) for C.T.R., in compari-
son with 1P3 for the Birmingham data.
The result for M.S.C.C. suggests that the
hospital population from which the series
was drawn was highly selected for younger
women, an inference that was drawn
(Prior & Waterhouse, 1977) from a
previous report from this centre (Berg
et al., 1968). The small difference between
C.T.R. and Birmingham could be due, in
part, to the statistical treatment of
coincidental tumours, as well as to a
differing age distribution at first primary
diagnosis.
An association between functionally
related sites such as breast and ovary
suggests thathormonalinfluences shouldat
least be considered as an explanation of
the relationship (Schoenberg, 1977). The
finding that the increased risk was confined
almost entirely to premenopausal patients
supports this view. Although the role of
hormones in the aetiology of breast cancer
is still far from clear, oestrogens are
regarded by some as the prime suspect,
mainly on the basis of animal experiments
and because some human tumours respond
to hormone therapy. Others favour a
theory of abnormal androgeni metabolism
(Bulbrook et al., 1971) while progesterone-
deficiency as a risk factor also has its
advocates (Sherman and Korenimann,
1974; Cowan, 1979). Epidemiological fac-
tors such as marital status, reproductive
history and early castration have been
found to be associated with the risk of
breast cancer, thereby suggesting that
ovarian activity, whether directly related
to hormones or not, plays some part in
tumour development. It seems unlikely
that a unified theory could account for the
whole spectrum of breast cancer, even one
as non-specific as "ovarian activity",
unless any abnormality in the endocrine
feed-back system represents a risk factor
for hormone-dependent tissues. Steroid
abnormalities may be multi-directional,
and relative proportions may be more
important than the absolute level of an
individual hormone (Lemon et al., 1966;
Wang et al., 1972).
Single status and low parity have also
been suggested as high-risk factors for
ovarian cancer. "Ovulatory age", that is
the number of ovarian cycles experienced,
has been shown to correlate directly with
risk (Casagrande et al., 1979). We found no
evidence to support an excess of single
women among those developing the two
tumours.
Although ovarian tumours have been
induced in animals by oestrogens (Jabara,
1962), oestrogens have only recently been
implicated in the human disease (Hoover
et al., 1977). In rats, implanted pituitary
tumours, secreting LH and FSH, induce
oestrogen-secreting granulosa-cell tumours
of the ovary which, on transplantation
to a new host, induce mammary tumours
(Iglesias, 1974). Pituitary stimulation
may be important in the human situation
with respect to ovarian cancers, but only
3-4% of human tumours are of the granu-
losa-cell type, more than 80% being
cystadenocarcinoma or solid adenocar-
cinomas, which are not usually hormone
secreting and, therefore, unlikely to be
responsible for the association with breast
cancer demonstrated here.
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Shermaii's hypothesis that low plasma
levels of progesterone, resulting from
inadequate functioning of the corpus
luteum, provide a setting favourable to
breast cancer might provide a link be-
tween both breast and ovarian cancer
with subfertility. Cowan's finding that
low levels of progesterone in infertile
women correlate with a high risk of breast
cancer would support this hypothesis.
Ovarian cycles of normal periodicity may
have short luteal phases with relatively
low progesterone levels. A few ovarian
tumours have shown some response to
treatment with progesterone (Varga &
Henrikson, 1964; Ward, 1972), thus suLg-
gesting the implication of progesterone
deficiency. A reduced feed-back of pro-
gesterone might increase the activity of
the pituitary and thus lead to increased
oestrogen levels via either the ovary or
even the adrenal cortex and, perhaps, to
an increased risk of breast cancer. How-
ever, we found no evidence of subfertility.
In the high-risk premenopausal group, 8
"ever-married" patients with two tumours
experienced a mean of 2-3 live births (even
when the one case for whom parity was
unknown was assessed as nulliparous)
compared with a completed family size
of 2 09 for women married between the
years 1940-44 (Central Statistical Office,
1974), and 50% experienced 3 or more
births, in comparison with 3100 in the
general population. Although the nuimbers
are very small for comparisons, they do
not suggest a high rate of subfertility.
Pedigree studies have shown a familial
link between ovarian and breast cancer,
which may be genetic and transmitted
via the male or female line (Lynch et al.,
1978). Familial cancer is characteristically
of early onset with a tendency to affect
multiple sites. The nature of the trans-
mitted gene is unknowvn, but it could in-
volve either hormonal production or
metabolism or, indeed, an enzyme system
affecting the potentiation of external
carcinogens.
Carcinogens in cigarette smoke and
indlllstrial pollutants may indtice relatively
early menopause and, in the presence of
suitable enzyme systems, increase the risk
of ovarian cancer (Mattison & Thorgeir-
sson, 1978). In multiple-regression analyses
of cancer mortality in North America,
environmental factors (in particular at-
mospheric pollution) were significant in
models for both breast and ovary. Cigar-
ette smoking, too, emerged as a significant
factor for ovarian cancer (Wellington
et al., 1979). This evidence, taken in con-
junction with that of Nomura (1973), who
induced cystadenomas (tumours which
are rare in rodents) in the progeny of
mice injected with urethane during gesta-
tion, suggests that an external carcinogen
might be a relevant factor in both ovarian
and breast cancer. The time at which the
carcinogen is encountered may also be
important, especially in relation to preg-
nancy, because it seems likely on the basis
of animal experiments that pregnancy
during exposure may confer protection.
Any protective effect in humans may not,
however, be detectable until the peri-
menopausal period.
Although many of the aetiological
factors suggested by the epidemiological
studies are common for both tumours, not
all may be relevant to the association
between breast and ovary. For instance,
because the risk of developing the two
tumours was highest in the premenopausal
group, early onset might suggest a familial
factor. However, in contrast with bilateral
breast cancer, for which high rates were
observed as early as 20-24 years of age
andwhich has a strong familial component,
the earliest first primarytumourinpatients
with both breast and ovarian cancer was
diagnosed at 35 years. Thus, those patients
with early onset may only represent a
group exposed at or soon after puberty,
when tissues of both organs may be
affected becauise they are particularly
susceptible at this time (Furth, 1973). The
effect of later exposures might be modified
byreproductiveexperience, thusproducing
an apparent decrease in risk with increas-
ing age. The level of protection might also
be different at the two sites. Although no
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direct relationship could be found between
the number ofpregnancies and the interval
between diagnoses it is of interest to note
that the one unmarried patient (of the
9 premenopausal patients with two
tumours) developed synchronous tumours
at the age of 43 years. In the remaining 8
patients, the breast tumour always pre-
sented first.
With very early initiation of the
tumours, a period of unopposed ovarian
cycling might be sufficient to explain the
progression of these tumours, without the
need to invoke any inherent hormonal
abnormality. Certainly, in the premeno-
pausal patients there was no evidence of
sub-fertility, but unfortunately we had
no information on the ages at which
pregnancies occurred, and could not assess
"ovulatory" age.
Ovarian activity has been implicated
in the induction of breast cancer in pre-
menopausal patients (MacMahon & Cole,
1972). Ethnic (MacMahon et al., 1974) and
familial differences in oestrogen levels
(Henderson et al., 1975) might implicate
genetic factors for breast cancer. Interest
has centred on relative oestrogen levels,
but if hyperoestrogenism is a relevant
factor in premenopausal breast-cancer
patients, an association between breast
and corpus uteri might be anticipated in
this age range. The association between
breast and corpus has been found only
inpost-menopausal patients (Bailar, 1963).
Therefore the association between breast
and ovary probably has a different
aetiology.
Unopposed oestrogen, then, seems an
unlikely explanation of the association
between breast and ovary, and the normal
levels of fertility suggest no radical
ovarian dysfunction. The simple explana-
tion could be that the association occurs
in women exposed to an external car-
cinogen at an early age or at least before a
first pregnancy. A period of continuous
ovarian cycling might be sufficient to
explain the promotion of initiated cells,
though it would be necessary to assume
that gonadotrophins are capable of pro-
ducing cell-division in the germinal layer
or stroma of the ovary. Mitosis of breast
cells may not be very extensive during the
menstrual cycle, but rapid and maximum
proliferation occurs with the first preg-
nancy, and an already-transformed cell
might also proliferate at this time and,
to a lesser extent, at subsequent preg-
nancies. However, during pregnancy high
levels of progesterone would inhibit
pituitary secretion, thus delaying the
development of an initiated ovarian
tumour. Such a delay might explain why,
in the high-risk premenopausal group, the
breast tumour presented first in each case
in married women.
The Multiple Primary Malignant Tumour Survey
is supported by Cancer Research Campaign.
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